查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573176

Cat 藥品市場：依產品類型、健康狀況、給藥途徑- 2025-2030 年全球預測

Cat Medicines Market by Product Type (Non-Prescription Medicines, Prescription Medicines), Health Condition (Digestive Health, Immune System Support, Joint Health), Route Of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年貓科藥物市場價值為153.5億美元，預計到2024年將達到161.2億美元，複合年成長率為6.31%，到2030年將達到235.6億美元。

貓科藥物市場包括多種用於診斷、治療和預防家貓疾病和健康問題的藥物。該細分市場包括抗寄生蟲藥物、抗生素和疫苗，為跳蚤、腸道寄生蟲和上呼吸道感染疾病等常見貓科疾病提供解決方案。伴同性動物世界的激增以及人們對寵物健康和保健意識的不斷增強證實了這個市場的需求。應用範圍從非處方藥到處方藥，為寵物飼主、獸醫和動物收容所等最終用戶提供服務。影響成長的主要因素是寵物人性化的趨勢，飼主將寵物視為家庭成員，增加了投資優質有效藥物的意願。此外，獸醫診斷和生物技術的進步使得更有針對性的治療方法的開發成為可能，創造了利潤豐厚的商機。公司可以透過投資研發來開發創新解決方案，例如個人化醫療以及天然和永續配方，從而利用這些趨勢。然而，市場開拓面臨動物用藥品核准嚴格法律規範、研發高成本挑戰。此外，新興市場的認知度低和無障礙度也是主要障礙。製藥公司和獸醫院之間的策略聯盟可以成為一種富有成效的市場拓展手段。創新可以圍繞著開發藥物來提高療效、減少副作用或針對當前未滿足的臨床需求，例如貓的衰老或慢性疾病。儘管這個市場擠滿了現有企業，競爭也很激烈，但對於專注於特定問題（例如貓過敏或新的藥物輸送機制）的利基新參與企業來說，也有空間。利用數位平台進行客戶參與和教育還可以在這個充滿活力但充滿挑戰的市場環境中開闢新的管道。

主要市場統計
基準年[2023] 153.5億美元
預測年份 [2024] 161.2億美元
預測年份 [2030] 235.6億美元
複合年成長率（%） 6.31%

市場動態：揭示快速發展的貓科藥物市場的關鍵市場洞察

供需的動態交互作用正在改變貓科動物藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 線上獸醫藥房服務的擴展使貓藥離家更近
    • 支持寵物健康和安全標準的政府法規影響市場成長
    • 涵蓋貓治療費用的寵物保險的增加推動了市場需求
    • 開發創新的藥物傳輸系統以促進貓科藥物的管理
  • 市場限制因素
    • 消費者對貓咪定期獸醫護理重要性的認知有限，尤其是在發展中地區。
    • 新貓藥的核准和商業化的嚴格監管要求限制了產品的可用性。
  • 市場機會
    • 針對寵物照護市場整體健康的創新貓保健補充品
    • 針對常見貓科疾病的先進處方藥，療效已被證實
    • 針對具有環保意識的飼主的永續且環保的貓藥
  • 市場挑戰
    • 對藥物療效和副作用的擔憂影響市場引入

波特的五力：駕馭貓科藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解貓科藥物市場的外部影響

外部宏觀環境因素在塑造貓科動物藥品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解貓醫藥市場的競爭狀況

對貓科動物藥品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣貓科藥物市場供應商的績效評估

FPNV定位矩陣是評估貓科藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了貓藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對貓科動物藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大線上獸藥服務進一步改善貓科藥物的獲取
      • 優先考慮寵物健康和安全標準的政府法規影響市場成長
      • 涵蓋貓治療費用的寵物保險的增加推動了市場需求
      • 開發創新的藥物輸送系統，以更輕鬆地給貓用藥
    • 抑制因素
      • 消費者對貓咪定期獸醫護理重要性的認知有限，尤其是在發展中地區
      • 新貓藥的核准和商業化的嚴格監管要求限制了產品的可用性
    • 機會
      • 創新的貓保健補充品瞄準寵物護理市場的整體健康
      • 先進的處方藥，已被證實對貓的常見疾病有效
      • 為具有環保意識的寵物飼主提供永續且環保的貓藥
    • 任務
      • 對藥物功效和副作用的擔憂影響市場採用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 Cat 藥品市場：依產品類型

  • 無處方箋藥物
    • 急救用品
    • 草藥療法
    • 食品補充品
    • 非處方止痛藥
    • 局部治療
  • 處方藥
    • 發炎藥
    • 抗生素
    • 荷爾蒙藥物
    • 止痛藥
    • 疫苗

第 7 章按健康狀況分類的 Cat 藥品市場

  • 消化器官系統健康
    • 膳食纖維補充品
    • 益生菌
  • 免疫系統支持
    • 抗氧化劑
  • 關節健康
    • 葡萄糖胺
  • 皮膚和毛皮健康
    • 緩解過敏
    • 歐米伽脂肪酸

第8章貓科藥物市場：依給藥途徑

  • 可注射的
    • 疫苗
  • 口服
    • 液體
    • 藥片
  • 話題
    • 奶油
    • 噴
  • 經皮的
    • 修補

第9章 Cat 美洲藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太貓科藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲貓藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-9A6A6F297DE3

The Cat Medicines Market was valued at USD 15.35 billion in 2023, expected to reach USD 16.12 billion in 2024, and is projected to grow at a CAGR of 6.31%, to USD 23.56 billion by 2030.

The cat medicines market encompasses a broad range of pharmaceutical products designed to diagnose, treat, and prevent diseases and health issues in domestic cats. This segment includes antiparasitics, antibiotics, and vaccines, offering solutions for common feline conditions such as fleas, intestinal worms, and upper respiratory infections. The growing adoption of companion animals worldwide and the increasing awareness of pet health and wellness underscore the necessity of this market. Applications range from over-the-counter medications to prescription drugs, serving end-users such as pet owners, veterinarians, and animal shelters. A major factor influencing growth is the rising trend of pet humanization, where owners treat pets as family members, thus increasing their willingness to invest in premium and effective medications. In addition, advances in veterinary diagnostics and biotechnology have enabled the development of more targeted treatments, creating lucrative opportunities. Companies can capitalize on these trends by investing in R&D to develop innovative solutions such as personalized medicine or natural, sustainable drug formulations. However, market growth faces challenges from stringent regulatory frameworks governing animal drug approvals and the high costs associated with research and development. Additionally, the lack of awareness or accessibility in emerging markets also poses a significant hurdle. Strategic collaborations between pharmaceutical companies and veterinary clinics could be a fruitful avenue for market expansion. Innovations can revolve around developing drugs with improved efficacy, fewer side effects, or those that target currently unmet clinical needs-such as aging and chronic conditions in cats. The market is competitive with established players, but it also offers room for niche newcomers focusing on specific issues like feline allergies or novel drug delivery mechanisms. Harnessing digital platforms for customer engagement and education can also open new channels in this vibrant yet challenging market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 15.35 billion
Estimated Year [2024] USD 16.12 billion
Forecast Year [2030] USD 23.56 billion
CAGR (%) 6.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cat Medicines Market

The Cat Medicines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of online veterinary pharmacy services making cat medicines more accessible
    • Government regulations favoring pet health and safety standards influencing market growth
    • Increase in pet insurance policies covering expenses for cat treatments driving market demand
    • Development of innovative drug delivery systems for easier administration of cat medications
  • Market Restraints
    • Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
    • Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
  • Market Opportunities
    • Innovative cat health supplements targeting holistic wellness in the pet care market
    • Advanced prescription medications for common feline illnesses with proven higher efficacy rates
    • Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
  • Market Challenges
    • Concerns over drug efficacy and side effects affect market adoption

Porter's Five Forces: A Strategic Tool for Navigating the Cat Medicines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cat Medicines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cat Medicines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cat Medicines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cat Medicines Market

A detailed market share analysis in the Cat Medicines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cat Medicines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cat Medicines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cat Medicines Market

A strategic analysis of the Cat Medicines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cat Medicines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Archer Daniels Midland Company, Bayer Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals, Elanco Animal Health, Heska Corporation, Hill's Pet Nutrition (Colgate-Palmolive), IDEXX Laboratories, Kindred Biosciences, Merck Animal Health, MWI Animal Health, Nestle Purina PetCare, PetIQ, Phibro Animal Health, Royal Canin, Vetoquinol, Virbac, and Zoetis.

Market Segmentation & Coverage

This research report categorizes the Cat Medicines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Non-Prescription Medicines and Prescription Medicines. The Non-Prescription Medicines is further studied across First Aid Products, Herbal Remedies, Nutritional Supplements, Over-The-Counter Pain Relief, and Topical Treatments. The Prescription Medicines is further studied across Anti-Inflammatory Drugs, Antibiotics, Hormonal Drugs, Pain Relievers, and Vaccines.
  • Based on Health Condition, market is studied across Digestive Health, Immune System Support, Joint Health, and Skin and Coat Health. The Digestive Health is further studied across Fiber Supplements and Probiotics. The Immune System Support is further studied across Antioxidants. The Joint Health is further studied across Glucosamine. The Skin and Coat Health is further studied across Allergy Relief and Omega Fatty Acids.
  • Based on Route Of Administration, market is studied across Injectable, Oral, Topical, and Transdermal. The Injectable is further studied across Vaccines. The Oral is further studied across Liquids and Tablets. The Topical is further studied across Creams and Sprays. The Transdermal is further studied across Patches.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of online veterinary pharmacy services making cat medicines more accessible
      • 5.1.1.2. Government regulations favoring pet health and safety standards influencing market growth
      • 5.1.1.3. Increase in pet insurance policies covering expenses for cat treatments driving market demand
      • 5.1.1.4. Development of innovative drug delivery systems for easier administration of cat medications
    • 5.1.2. Restraints
      • 5.1.2.1. Limited consumer awareness about the importance of regular veterinary care for cats especially in developing regions
      • 5.1.2.2. Stringent regulatory requirements for the approval and commercialization of new cat medications limiting product availability
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative cat health supplements targeting holistic wellness in the pet care market
      • 5.1.3.2. Advanced prescription medications for common feline illnesses with proven higher efficacy rates
      • 5.1.3.3. Sustainable and eco-friendly cat medications aiming at environmental-conscious pet owners
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over drug efficacy and side effects affect market adoption
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cat Medicines Market, by Product Type

  • 6.1. Introduction
  • 6.2. Non-Prescription Medicines
    • 6.2.1. First Aid Products
    • 6.2.2. Herbal Remedies
    • 6.2.3. Nutritional Supplements
    • 6.2.4. Over-The-Counter Pain Relief
    • 6.2.5. Topical Treatments
  • 6.3. Prescription Medicines
    • 6.3.1. Anti-Inflammatory Drugs
    • 6.3.2. Antibiotics
    • 6.3.3. Hormonal Drugs
    • 6.3.4. Pain Relievers
    • 6.3.5. Vaccines

7. Cat Medicines Market, by Health Condition

  • 7.1. Introduction
  • 7.2. Digestive Health
    • 7.2.1. Fiber Supplements
    • 7.2.2. Probiotics
  • 7.3. Immune System Support
    • 7.3.1. Antioxidants
  • 7.4. Joint Health
    • 7.4.1. Glucosamine
  • 7.5. Skin and Coat Health
    • 7.5.1. Allergy Relief
    • 7.5.2. Omega Fatty Acids

8. Cat Medicines Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Injectable
    • 8.2.1. Vaccines
  • 8.3. Oral
    • 8.3.1. Liquids
    • 8.3.2. Tablets
  • 8.4. Topical
    • 8.4.1. Creams
    • 8.4.2. Sprays
  • 8.5. Transdermal
    • 8.5.1. Patches

9. Americas Cat Medicines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cat Medicines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cat Medicines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aratana Therapeutics
  • 2. Archer Daniels Midland Company
  • 3. Bayer Animal Health
  • 4. Boehringer Ingelheim
  • 5. Ceva Sante Animale
  • 6. Dechra Pharmaceuticals
  • 7. Elanco Animal Health
  • 8. Heska Corporation
  • 9. Hill's Pet Nutrition (Colgate-Palmolive)
  • 10. IDEXX Laboratories
  • 11. Kindred Biosciences
  • 12. Merck Animal Health
  • 13. MWI Animal Health
  • 14. Nestle Purina PetCare
  • 15. PetIQ
  • 16. Phibro Animal Health
  • 17. Royal Canin
  • 18. Vetoquinol
  • 19. Virbac
  • 20. Zoetis

LIST OF FIGURES

  • FIGURE 1. CAT MEDICINES MARKET RESEARCH PROCESS
  • FIGURE 2. CAT MEDICINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CAT MEDICINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CAT MEDICINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CAT MEDICINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CAT MEDICINES MARKET DYNAMICS
  • TABLE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY FIRST AID PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CAT MEDICINES MARKET SIZE, BY OVER-THE-COUNTER PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CAT MEDICINES MARKET SIZE, BY HORMONAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CAT MEDICINES MARKET SIZE, BY PAIN RELIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CAT MEDICINES MARKET SIZE, BY FIBER SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CAT MEDICINES MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CAT MEDICINES MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CAT MEDICINES MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CAT MEDICINES MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CAT MEDICINES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CAT MEDICINES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CAT MEDICINES MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CAT MEDICINES MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 265. TAIWAN CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 266. TAIWAN CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 267. TAIWAN CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 268. TAIWAN CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. THAILAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 278. THAILAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 279. THAILAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 280. THAILAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 281. THAILAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 289. VIETNAM CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. VIETNAM CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 291. VIETNAM CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 292. VIETNAM CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 293. VIETNAM CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 294. VIETNAM CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 316. DENMARK CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. DENMARK CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 318. DENMARK CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 319. DENMARK CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 320. DENMARK CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 321. DENMARK CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 322. DENMARK CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 323. DENMARK CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 324. DENMARK CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 325. DENMARK CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 326. DENMARK CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 327. DENMARK CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 328. DENMARK CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 329. EGYPT CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. EGYPT CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 331. EGYPT CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 332. EGYPT CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 333. EGYPT CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 334. EGYPT CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 335. EGYPT CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 336. EGYPT CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 337. EGYPT CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 338. EGYPT CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 339. EGYPT CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 340. EGYPT CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 341. EGYPT CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 342. FINLAND CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. FINLAND CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 344. FINLAND CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 345. FINLAND CAT MEDICINES MARKET SIZE, BY HEALTH CONDITION, 2018-2030 (USD MILLION)
  • TABLE 346. FINLAND CAT MEDICINES MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
  • TABLE 347. FINLAND CAT MEDICINES MARKET SIZE, BY IMMUNE SYSTEM SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 348. FINLAND CAT MEDICINES MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 349. FINLAND CAT MEDICINES MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2030 (USD MILLION)
  • TABLE 350. FINLAND CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. FINLAND CAT MEDICINES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 352. FINLAND CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 353. FINLAND CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 354. FINLAND CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
  • TABLE 355. FRANCE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. FRANCE CAT MEDICINES MARKET SIZE, BY NON-PRESCRIPTION MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 357. FRANCE CAT MEDICINES MARKET SIZE, BY PRESCRIPTION MEDICINES, 2018-2030 (USD